Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Home CompaniesNewCardio Inc

NewCardio Inc

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
0.0001 USD 0.00(0%)
Last update at 2026-11-11T21:00:00Z
VOLUME
4000
Market Cap
0.05M

Momentum Score

…

NewCardio, Inc., a cardiac diagnostic and services company, focuses on the research, development, and commercialization of proprietary software platform technology solutions for the non-invasive diagnosis and monitoring of cardiovascular disease (CVD), as well as the cardiac safety assessment of drugs under development. The company's technology platform provides real-time and 3-D analysis of the heart's electrical activity as detected at the body surface by standard 12-lead electrocardiogram (ECG) electrodes. Its developing products include QTinno, an automated cardiac safety solution that replaces the manual and/or semi-automated methodologies with algorithms that automatically measure, analyze, and report on the ECGs collected; and CardioBip, a mobile ECG transtelephonic system comprising a mobile ECG recording and transmitting device, and a Web enabled software which receives, processes, and analyzes the data. The company is also developing my3KG, a software application to provide a method to assess cardiac electrical activity in time and space. NewCardio, Inc. was founded in 2004 and is based in Branchburg, New Jersey.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on NewCardio Inc (OTC: NWCI) is limited; available disclosures provide few verifiable details about its business activities or products. Because material operational and commercial information is sparse, identifiable long-term growth drivers cannot be confirmed, and investors may be attracted primarily by speculative upside common to small, thinly traded OTC companies.
The principal risks include limited disclosure and transparency, thin trading liquidity, lack of proven operations or revenue history, potential financial and governance uncertainty, and elevated execution and information risk.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
2.78%
Revenue TTM
0.24M
Revenue Per Share
0.01
Gross Profit TTM
0.11M
Debt / Equity
-
ROE
-
Net Debt
-
ROCE
1233.50%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2010-12-31 2009-12-31 2008-12-31 2007-12-31
Type yearly yearly yearly yearly
Date 2010-12-31 2009-12-31 2008-12-31 2007-12-31
Income before tax -11.50M -9.59M -14.18M -3.19M
Minority interest 0.00M 0.00M 0.00M 0.00M
Net income -11.50M -9.59M -14.18M -3.19M
Selling general administrative 5.92M 6.90M 5.68M 1.73M
Gross profit 0.11M 0.00M 0.00M 0.00M
Ebit -9.46M -10.01M -7.83M -2.10M
Non operating income net other 0.00M 0.00M 0.00M 0.00M
Operating income -9.46M -10.01M -7.83M -2.10M
Other operating expenses 0.00M 0.00M 0.00M 0.00M
Interest expense 0.00M 0.00M 0.00M 0.00M
Extraordinary items 0.00M 0.00M 0.00M 0.00M
Non recurring 0.00M 0.00M 0.00M 0.00M
Other items 0.00M 0.00M 0.00M 0.00M
Income tax expense 0.00M 0.00M 0.00M 0.00M
Total revenue 0.26M 0.00M 0.00M 0.00M
Total operating expenses 9.72M 10.01M 7.83M 2.10M
Cost of revenue 0.15M 0.00M 0.00M 0.00M
Total other income expense net -2.04M 0.42M -6.35M -1.08M
Discontinued operations 0.00M 0.00M 0.00M 0.00M
Net income from continuing ops -11.50M -9.59M -14.18M -3.19M
Net income applicable to common shares -11.50M -10.37M -14.94M -6.00M
Preferred stock and other adjustments 0.00M 0.00M 0.00M 0.00M
Breakdown 2010-12-31 2009-12-31 2008-12-31 2007-12-31
Type yearly yearly yearly yearly
Date 2010-12-31 2009-12-31 2008-12-31 2007-12-31
Total assets 2.85M 2.30M 4.72M 6.48M
Intangible assets 0.06M 0.00M 0.00M 0.00M
Other current assets 1.96M 0.56M 0.00M 0.00M
Total liab 6.01M 2.99M 1.60M 5.68M
Total stockholder equity -3.16M -1.47M 3.12M -1.28M
Deferred long term liab 0.00M 0.00M 0.00M 0.00M
Other current liab 0.00M 0.74M 0.74M 0.00M
Common stock 0.03M 0.02M 0.02M 0.02M
Retained earnings -42.43M -30.93M -21.34M -7.16M
Other liab 2.39M 1.77M 0.00M 4.80M
Good will 0.00M 0.00M 0.00M 0.00M
Other assets 0.02M 0.02M 0.02M 0.00M
Cash 0.58M 1.39M 2.32M 1.48M
Total current liabilities 3.62M 1.22M 1.60M 0.88M
Short term debt 0.00M 0.00M 0.00M 0.00M
Short long term debt 0.00M 0.00M 0.01M 0.01M
Other stockholder equity 0.00M 0.00M 0.00M 0.00M
Property plant equipment 0.16M 0.20M 0.11M 0.01M
Total current assets 2.62M 2.08M 4.59M 6.48M
Long term investments 0.00M 0.00M 0.00M 0.00M
Net tangible assets -3.21M -1.47M 3.12M -1.28M
Short term investments 0.00M 0.03M 2.14M 5.00M
Net receivables 0.04M - - -
Long term debt 0.00M 0.00M 0.00M 0.00M
Inventory 0.00M 0.00M 0.00M 0.00M
Accounts payable 0.62M 0.48M 0.84M 0.87M
Total permanent equity 0.00M 0.00M 0.00M 0.00M
Noncontrolling interest in consolidated entity 0.00M 0.00M 0.00M 0.00M
Temporary equity redeemable noncontrolling interests 0.00M 0.00M 0.00M 0.00M
Accumulated other comprehensive income 0.00M 0.00M 0.00M 0.00M
Additional paid in capital 0.00M 0.00M 0.00M 0.00M
Common stock total equity 0.00M 0.00M 0.00M 0.00M
Preferred stock total equity 0.00M 0.00M 0.00M 0.00M
Retained earnings total equity 0.00M 0.00M 0.00M 0.00M
Treasury stock 0.00M 0.00M 0.00M 0.00M
Accumulated amortization 0.00M 0.00M 0.00M 0.00M
Non currrent assets other 0.00M 0.00M 0.00M 0.00M
Deferred long term asset charges 0.00M 0.00M 0.00M 0.00M
Non current assets total 0.00M 0.00M 0.00M 0.00M
Capital lease obligations 0.00M 0.00M 0.00M 0.00M
Long term debt total 0.00M 0.00M 0.00M 0.00M
Breakdown 2010-12-31 2009-12-31 2008-12-31 2007-12-31
Type yearly yearly yearly yearly
Date 2010-12-31 2009-12-31 2008-12-31 2007-12-31
Investments 0.03M 2.12M 2.86M -5.00M
Change to liabilities 0.20M -0.36M -0.09M 0.36M
Total cashflows from investing activities -0.07M 1.97M 2.73M -5.01M
Net borrowings 3.00M -0.01M -0.01M 0.16M
Total cash from financing activities 3.83M 2.74M 2.80M 7.62M
Change to operating activities 0.08M -0.02M -0.14M -0.14M
Net income -11.50M -9.59M -14.18M -3.19M
Change in cash -0.80M -0.94M 0.85M 1.48M
Total cash from operating activities -4.56M -5.65M -4.69M -1.13M
Depreciation 0.08M 0.06M 0.02M 0.00M
Other cashflows from investing activities 0.00M 0.00M 0.00M 0.00M
Dividends paid 0.00M 0.00M 0.00M 0.00M
Change to inventory 0.00M 0.00M 0.00M 0.00M
Change to account receivables -0.04M -0.04M -0.04M -0.04M
Sale purchase of stock 0.00M 0.00M 0.00M 0.00M
Other cashflows from financing activities 0.00M 0.00M 0.00M 0.00M
Change to netincome 4.72M 3.88M 9.70M 1.68M
Capital expenditures 0.04M 0.15M 0.12M 0.01M
Change receivables 0.00M 0.00M 0.00M 0.00M
Cash flows other operating 0.00M 0.00M 0.00M 0.00M
Exchange rate changes 0.00M 0.00M 0.00M 0.00M
Cash and cash equivalents changes 0.00M 0.00M 0.00M 0.00M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
NWCI
NewCardio Inc		 -
-%		 0.00 - - 0.21 - 0.21 -0.01
ABT
Abbott Laboratories		 -0.71
0.65%		 108.58 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 0.28
0.28%		 101.89 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 -2.16
0.68%		 316.63 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 -
-%		 47.31 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

NewCardio Inc

NewCardio, Inc., a cardiac diagnostic and services company, focuses on the research, development, and commercialization of proprietary software platform technology solutions for the non-invasive diagnosis and monitoring of cardiovascular disease (CVD), as well as the cardiac safety assessment of drugs under development. The company's technology platform provides real-time and 3-D analysis of the heart's electrical activity as detected at the body surface by standard 12-lead electrocardiogram (ECG) electrodes. Its developing products include QTinno, an automated cardiac safety solution that replaces the manual and/or semi-automated methodologies with algorithms that automatically measure, analyze, and report on the ECGs collected; and CardioBip, a mobile ECG transtelephonic system comprising a mobile ECG recording and transmitting device, and a Web enabled software which receives, processes, and analyzes the data. The company is also developing my3KG, a software application to provide a method to assess cardiac electrical activity in time and space. NewCardio, Inc. was founded in 2004 and is based in Branchburg, New Jersey.

PO Box 658, Branchburg, NJ, United States, 08853

877-332-4324

10

Name Title Year Born
Dr. Jess Emery Jones M.D. CEO & Director 1979
Mr. Greg Sadowski Chief Operating Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PARA
USD 0.10
+38.58%
LUNR
USD 13.91
+14.20%
MBGL
USD 22.63
+13.60%
FRMI
USD 2.04
+12.71%
FIGR
USD 26.97
+11.49%
CDNL
USD 6.09
-59.37%
ADIG
USD 11.79
-39.79%
CTVA
USD 9.21
-24.11%
BZ
USD 12.99
-22.28%
ENVX
USD 1.98
-21.70%

Equity Sectors*

  • Basic Materials

    -1.40%

  • Communication Services

    -0.45%

  • Consumer Cyclical

    -0.55%

  • Consumer Defensive

    -0.01%

  • Energy

    -0.01%

  • Financial Services

    -0.40%

  • Financials

    -0.15%

  • Healthcare

    -1.15%

  • Industrials

    -0.46%

  • Real Estate

    -0.29%

  • Technology

    -1.22%

  • Utilities

    -0.10%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…